Antimicrobial Stewardship: Guidelines
SHEA has partnered with IDSA for over a decade to develop treatment guidelines and programmatic recommendations for antimicrobial stewardship.
Please also see the IDSA Guidelines Webpage on Antimicrobial Agent Use.
Author: Sara E. Cosgrove, Elizabeth D. Hermsen, Michael J. Rybaka, Thomas M. File, Sarah K. Parker and Tamar F. Barlama
Date Published: December 2014
Publication Format: HTML
Abstract: The purpose of this guidance document is to outline the knowledge and skills that are needed to lead an antimicrobial stewardship program. It was developed by antimicrobial stewardship experts from organizations that are engaged in advancing the field of antimicrobial stewardship.
Author: The American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology of America (SHEA)
Date Published: Feb 04, 2013
Date Revised: Feb, 2013 (American Journal of Health-System Pharmacy and Surgical Infections)
Publication Format: HTML
Abstract: The guidelines are intended to provide practitioners with a standardized approach to the rational, safe, and effective use of antimicrobial agents for the prevention of surgical-site infections (SSIs) based on currently available clinical evidence and emerging issues.
Author: Joint SHEA/IDSA Taskforce
Date Published: Jan, 01 2007
Publication Format: PDF
Abstract: This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy. The combination of effective antimicrobial stewardship with a comprehensive infection control program has been shown to limit the emergence and transmission of antimicrobial‐resistant bacteria and reduce healthcare costs without adversely impacting quality-of-care. These guidelines focus on the development of effective hospital‐based stewardship programs and do not include specific outpatient recommendations. The population targeted includes all patients in acute care hospitals.
Author: SHEA/IDSA Joint Committee on the Prevention of Antimicrobial Resistance
Date Published: April 1997, CID
Abstract: Antimicrobial resistance results in increased morbidity, mortality, and costs of healthcare. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.